Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| TM63C | Q9P1W3 | Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63C) (hTMEM63C) | Disease related genesHuman disease related genesPotential drug targets | 11 | Hereditary spastic paraplegia | Other mediation | 2 | 0.28 | ||
| TMC5A | Q8N6Q1 | Transmembrane and coiled-coil domain-containing protein 5A | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.28 | |||
| TMPS2 | O15393 | Transmembrane protease serine 2 (EC 3.4.21.122) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] | Cancer-related genesEnzymesPredicted intracellular proteins | 1 | COVID-19Middle East Respiratory SyndromeSevere acute respiratory syndrome | Clinical-translation mediationMetabolism mediation | 2 | 0.28 | ||
| TNR25 | Q93038 | Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death) (LARD) (Protein WSL) (Protein WSL-1) | 1 | Solid tumour/cancer | Clinical-translation mediationImmune mediation | 2 | 0.28 | |||
| TNR8 | P28908 | Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30) | Cancer-related genesCD markersFDA approved drug targets | 1 | B-cell lymphomaDiabetes mellitusFollicular lymphoma | Clinical-translation mediationImmune mediation | 2 | 0.28 | ||
| TR10D | Q9UBN6 | Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2) (DcR2) (TNF-related apoptosis-inducing ligand receptor 4) (TRAIL receptor 4) (TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264) | 1 | Immune mediation | 2 | 0.28 | ||||
| TRPV3 | Q8NET8 | Transient receptor potential cation channel subfamily V member 3 (TrpV3) (Vanilloid receptor-like 3) (VRL-3) | 6 | DepressionDiabetes mellitusPain | Clinical-translation mediationFusion and delivery mediation | 2 | 0.28 | |||
| TSN1 | O60635 | Tetraspanin-1 (Tspan-1) (Tetraspan NET-1) (Tetraspanin TM4-C) | Predicted membrane proteins | 4 | Fusion and delivery mediation | 2 | 0.28 | |||
| TTYH3 | Q9C0H2 | Protein tweety homolog 3 (hTTY3) (Volume-regulated anion channel subunit TTYH3) | Predicted membrane proteinsTransporters | 5 | Fusion and delivery mediation | 2 | 0.28 | |||
| ALK | Q9UM73 | ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) | Cancer-related genesCD markersDisease related genes | 1 | Adrenal cancerBreast cancerColorectal cancer | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.28 |